SYNAPS Dx Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$10M
- Investors
-
1
SYNAPS Dx General Information
Description
Developer of an Alzheimer's disease diagnostic tool designed to commercialize the biomarker technology. The company researches, develops, and commercializes diagnostics for neurodegenerative disorders and conditions, enabling healthcare professionals with the necessary scientific data to identify Alzheimer's Disease and distinguish it from other dementias.
Contact Information
Website
www.synapsdx.comCorporate Office
- 12441 Parklawn Drive
- Suite 2A
- Rockville, MD 20852
- United States
Corporate Office
- 12441 Parklawn Drive
- Suite 2A
- Rockville, MD 20852
- United States
SYNAPS Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC (Series A) | 13-Oct-2021 | $10M | Completed | Generating Revenue |
SYNAPS Dx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
SYNAPS Dx Comparisons
Industry
Financing
Details
SYNAPS Dx Competitors (23)
One of SYNAPS Dx’s 23 competitors is T2 Biosystems, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| T2 Biosystems | Formerly VC-backed | Lexington, MA | ||||
| Meridian Bioscience | Private Equity-Backed | Cincinnati, OH | ||||
| Optina Diagnostics | Venture Capital-Backed | Montreal, Canada | ||||
| RetiSpec | Venture Capital-Backed | Toronto, Canada | ||||
| Cepheid | Formerly VC-backed | Sunnyvale, CA |
SYNAPS Dx Signals
SYNAPS Dx Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Semler Scientific | Corporation | Minority |
SYNAPS Dx FAQs
-
When was SYNAPS Dx founded?
SYNAPS Dx was founded in 2016.
-
Where is SYNAPS Dx headquartered?
SYNAPS Dx is headquartered in Rockville, MD.
-
What is the size of SYNAPS Dx?
SYNAPS Dx has 19 total employees.
-
What industry is SYNAPS Dx in?
SYNAPS Dx’s primary industry is Diagnostic Equipment.
-
Is SYNAPS Dx a private or public company?
SYNAPS Dx is a Private company.
-
What is the current valuation of SYNAPS Dx?
The current valuation of SYNAPS Dx is .
-
What is SYNAPS Dx’s current revenue?
The current revenue for SYNAPS Dx is .
-
How much funding has SYNAPS Dx raised over time?
SYNAPS Dx has raised $10M.
-
Who are SYNAPS Dx’s investors?
Semler Scientific has invested in SYNAPS Dx.
-
Who are SYNAPS Dx’s competitors?
T2 Biosystems, Meridian Bioscience, Optina Diagnostics, RetiSpec, and Cepheid are some of the 23 competitors of SYNAPS Dx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process